Platelet-rich fibrin gel for diabetic foot ulcers
Treatments studied
Part of Heart & circulation, Hormones & metabolism, Immune system & allergy, Skin clinical trials.
This trial tests a special gel made from your own blood (platelet-rich fibrin, or PRF) to help heal diabetic foot ulcers that are not getting better with standard care. It may be an option if you have a mild-to-moderate ulcer on the bottom of your foot with good blood flow and no infection.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older and have type 1 or type 2 diabetes.
- Your foot ulcer is on the bottom of your foot, below the ankle, not between the toes, and it's been there for at least 30 days.
- The ulcer is between the size of a dime and a small apple (1 to 12 square centimeters), and less than about a quarter-inch deep, with no exposed bone or tendon.
- There is no active infection in the wound, and you have good blood flow to your foot (checked with a simple test).
- You are willing to wear a special boot to keep pressure off the ulcer and follow up for about 14 days of standard care before starting the study treatment.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This Phase 1 study tests whether stem cells taken from fat tissue (after a small procedure) can help heal a long-lasting diabetic foot ulcer. It mainly aims to help ulcers that are limited to soft tissue and have good blood flow to the foot.
This study tests whether a special placental tissue graft placed on a diabetic foot ulcer helps it heal faster than standard wound care alone. It is for people with a diabetic foot ulcer that has not healed after 4 weeks of usual care.
This trial tests whether a special treatment using placental cells can help heal diabetic foot ulcers that haven't healed with standard care. If you qualify, you may receive this cell-based treatment to see if it helps your wound close faster and reduce the risk of complications.
This study tests a new wound therapy for diabetic foot ulcers that haven't healed with standard care. It aims to see if the therapy helps these ulcers heal better and faster.
This Phase 3 trial tests ENERGI-F703 gel to help heal diabetic foot ulcers that have not improved for at least 4 weeks. It may help some people whose wounds meet specific size and non-infection criteria.
This study tests whether a special preparation of your own fat tissue, processed with a device called SyntrFuge, can help heal diabetic foot ulcers. The goal is to see if this treatment is safe and effective in closing these hard-to-heal wounds.
Hear when a new Diabetic Foot Ulcer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.